Current position:Home >Product >
Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-(872002-72-7)
- Name: Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
- Synonyms:
- Molecular Formula:
- Molecular Weight:476.624
- CAS Registry Number:872002-72-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.872002-72-7 6-[(4-{2-[4-(2-Methyl-2-propanyl)phenyl]-1H-benzimidazol-4-yl}-1- piperazinyl)methyl]quinoxaline
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 909106-60-1/A 876828
- 909106-97-4/A 924825
- 914088-64-5/Cazpaullone
- 700874-71-1/LY2109761
- 1003883-60-0/1,2-Pyrrolidinedicarboxamide, N1-(4-chlorophenyl)-N2-[(4-chlorophenyl)methyl]-N2-(2-hydroxyethyl)-, (2R)-
- 1003882-41-4/1,2-Pyrrolidinedicarboxamide, N2-[(4-chlorophenyl)methyl]-N2-methyl-N1-[4-(trifluoromethyl)phenyl]-, (2R)-
- 212790-31-3/CP 481715
- 864947-20-6/3-Azabicyclo[3.1.0]hexane-2-carboxamide, N-[1-(cyclopropylmethyl)-2,3-dioxo-3-(2-propen-1-ylamino)propyl]-3-[(2S)-2-[[[[(1S)-1-[(4,4-dimethyl-2,6-dioxo-1-piperidinyl)methyl]-2,2-dimethylpropyl]amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-
- 459133-38-1/Phenol, 5-[(7-chloro-4-quinolinyl)amino]-2-[[(1,1-dimethylethyl)amino]methyl]-
- 608141-41-9/ApreMilast
- 866467-28-9/1-Naphthalenecarboxamide, N-[(3aR,6S,6aS)-octahydro-1-(N-methyl-L-alanyl-3-methyl-L-valyl)cyclopenta[b]pyrrol-6-yl]-
- 957211-19-7/1(2H)-Quinolineethanol, 3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]-a-(trifluoromethyl)-, (aS,2R)-
- 1044281-58-4/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6R,7R)-
- 1117752-22-3/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6S,7S)-
- 260540-97-4/4-Quinolinamine, 7-chloro-N-[3-[[(1,1-dimethylethyl)amino]methyl]-4-fluorophenyl]-
- 1019839-52-1/Dibenzo[b,f][1,4]thiazepine-8-carboxamide, N-butyl-11-(3-chloro-4-fluorophenyl)-
- 872002-72-7/Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
- 884339-27-9/N-[4-[(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-N'-[2-methoxy-5-(trifluoromethyl)phenyl]-
- 917369-31-4/N-(4-Methoxyphenyl)-N,2-dimethyl-4-quinazolinamine hydrochloride
- 1144161-05-6/Benzamide, N-[1,2-dihydro-2-(4-methoxyphenyl)-1-oxopyrido[2,3-e][1,2,4]triazolo[4,3-a]pyrazin-4-yl]-
- 1052112-65-8/2-Propyn-1-ol, 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-, 2,2,2-trifluoroacetate (1:2)
- 842148-40-7/AKT Kinase Inhibitor
- 66774-80-9/Inhoffen Lythgoe Diol Monotosylate
- 141404-08-2/Cyclohexanone, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4-hydroxy-, (3R, 5R)
- 66774-71-8/Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester
- 886859-14-9/2-Thiophenecarboxamide, 3-[(1R)-1-[2-(difluoromethoxy)-4-[[(1,1-dimethylethyl)amino]methyl]phenyl]ethoxy]-5-imidazo[1,2-a]pyridin-3-yl-
- 321688-88-4/2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime]
- 1239513-63-3/Poloxipan
- 866772-52-3/Benzeneacetamide, α-(cyclopentylmethyl)-N-(5-methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-methyl-1-piperazinyl)sulfonyl]-, (αR)-
- 258870-13-2/Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-